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Abstract 
Background—T NADPH oxidase, by generating reactive oxygen species, is involved in the 
pathophysiology of many cardiovascular diseases and represents a therapeutic target for the 
development of novel drugs. A single-nucleotide polymorphism (SNP) C242T of the p22phox 
subunit of NADPH oxidase has been reported to be negatively associated with coronary heart 
disease (CHD) and may predict disease prevalence. However, the underlying mechanisms 
remain unknown. 
Methods and Results—Using computer molecular modelling we discovered that C242T SNP 
causes significant structural changes in the extracellular loop of p22phox and reduces its 
interaction stability with Nox2 subunit. Gene transfection of human pulmonary microvascular 
endothelial cells showed that C242T p22phox reduced significantly Nox2 expression but had no 
significant effect on basal endothelial O2.- production or the expression of Nox1 and Nox4. When 
cells were stimulated with TNFĮ (or high glucose), C242T p22phox inhibited significantly TNFĮ-
induced Nox2 maturation, O2.- production, MAPK and NFțB activation and inflammation (all 
p<0.05). These C242T effects were further confirmed using p22phox shRNA engineered HeLa 
cells and Nox2-/- coronary microvascular endothelial cells. Clinical significance was investigated 
using saphenous vein segments from non CHD subjects after phlebectomies. TT (C242T) allele 
was common (prevalence of ~22%) and compared to CC, veins bearing TT allele had 
significantly lower levels of Nox2 expression and O2.-  generation in response to high glucose 
challenge.  
Conclusions—C242T SNP causes p22phox structural changes that inhibit endothelial Nox2 
activation and oxidative response to TNFĮ or high glucose stimulation. C242T SNP may 
represent a natural protective mechanism against inflammatory cardiovascular diseases.  
Key words: genetics; endothelial dysfunction; NAD(P)H oxidase; oxidative stress; vessel 
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Introduction 
Single-nucleotide polymorphisms (SNP) are one base variations in DNA sequences that occur in 
at least 1% of the population1. Although most SNPs have little or no effect on human health, 
some can predispose individuals to disease or have a major impact on the physiological response 
to environmental challenges or to drugs1, 2.  Vascular endothelial cells express constitutively a 
Nox2 (also called gp91phox) containing NADPH oxidase, which by generating superoxide (O2.-) 
plays an important role in oxidative stress-related endothelial dysfunction and cardiovascular 
diseases (CVD)3-7. The Nox2 catalytic subunit requires p22phox in a 1:1 ratio to form the 
cytochrome b558 complex to produce O2.-, and structural changes of p22phox may affect its 
interaction with Nox2. In the context of Nox2-derived oxidative stress and CVD, SNPs of the 
p22phox have attracted significant attention recently. 
 The p22phox is encoded by the CYBA gene located on the long arm of chromosome 16 at 
position 24. It spans 8.5 kb and is composed of six exons and five introns encoding an open 
reading frame of approximately 600 bp8. The p22phox has three structural domains: 1) a 
hydrophobic N-terminal domain consisting of three transmembrane helices; 2) a hydrophilic 
extracellular region; and 3) a cytosolic tail featuring a proline rich region (PRR)9, 10. So far, 
seven SNPs of the p22phox gene have been reported i.e. C242T, A640G; C549T; A930G; A675T; 
C852G and C536T11, and only two of them (C242T and C549T) are translated into the protein. 
The C549T SNP changes an Ala174 to Val174 without any reported significant functional effect11. 
In contrast, the C242T SNP changes His72 to Tyr72 that is located in the extracellular loop of the 
putative Nox2 binding region12 and has been reported in several studies to be negatively 
associated with CVD, such as hypertension, atherosclerosis, and myocardial infarction and to 
reduce oxidative burst in neutrophils11,13-15. However, others have found that the C242T variant 
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had no effect on cardiovascular disease progression16 or even increased ROS production in CVD 
arteries17,18. Given the contradictory evidence, it is important to elucidate the molecular 
mechanism responsible for the effects of p22phox C242T SNP on inhibiting endothelial Nox2 
activity and vascular oxidative stress in order to ascertain its effect on CVD.  
 In this study, we used computer structural modeling plus molecular and biochemical 
approaches to elucidate the mechanism of p22phox C242T SNP inhibition of endothelial Nox2 
activation and oxidative stress in response to TNFĮ or high glucose stimulation. Results were 
further confirmed using engineered p22phox depleted (p22phox-depl) HeLa cells, primary coronary 
microvascular endothelial cells (CMEC) isolated from Nox2-/- mice and saphenous vein 
segments of patients without history of coronary heart diseases (CHD) after phlebectomies. We 
report for the first time that C242T SNP is linked to the p22phox extracellular domain 
morphological change that interferes with Nox2 binding stability and inhibits endothelial 
oxidative stress and inflammatory response to TNFĮ or high glucose challenges.  
 
Materials and methods 
The in silico p22phox model was generated as reported previously by incorporating data from 
online prediction servers with the molecular operating environment (MOE; Chemical Computing 
Group Inc., Canada) and subjected to energy minimization using the AMBER99 forcefield9,10. 
The docking of p22phox with Nox2 peptides was performed in the MOE10. HapMap analysis of 
the CYBA gene was performed using the International HapMap Project (HapMap phase II+III; 
dbSNP b126) and six common CYBA SNPs were chosen from the National Centre for 
Biotechnology Information (NCBI) SNP database (dbSNP). Haplotype association was 
calculated using the Haplo-view analysis program (version 4.2) in the northern and western 
 by guest on June 2, 2016http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.116.021993 
5 
European population (CEU). Human pulmonary microvascular endothelial cells (HPMEC-
ST1.6R) were a kind gift from Dr R. Unger (Johannes Gutenberg University, Germany)19. 
Mouse CMEC were isolated from the hearts of ~12 week old Nox2-/- and WT mice and cultured 
as described previously20,21. The shRNA p22phox (p22phox-depl) and shRNA scrambled control 
HeLa cells were generated as described previously22 in the laboratory of Professor Krönke 
(University of Cologne, Germany). Segments of human saphenous vein were collected from 36 
patients (without history of CHD) undergoing phlebectomies at a specialist vein unit. Informed 
consents were obtained from the patients and the project was approved by the local NHS and the 
university ethical committees according to UK regulation. The IRB approval was obtained 
according to the guidelines noted in the Circulation Instruction to Authors. The C to T 
substitution at position 242 in the CYBA coding sequence was examined as described 
previously23. ROS production was measured using four independent methods as described 
previously24: 1) Lucigenin-chemiluminescence; 2) DHE fluorescence HPLC assay with or 
without superoxide dismutase–polyethylene glycol (PEG-SOD)4,25; 3) DHE flow cytometry; and 
4) DCF fluorescence. 
See the online-only Data Supplement for a full description of materials and methods. 
Statistics  
Data were presented as means r SD in figures. For cell culture experiments, results were taken 
from at least 3 independent cell cultures and gene transfections for each condition. In the case of 
CMEC isolation, 6 mice/per group were used for each isolation and the data presented were the 
means r SD from at least 3 separate CMEC isolations. Comparisons were made by ANOVA 
with Bonferroni post hoc correction or as indicated in the figure legend. Values of P<0.05 were 
considered statistically significant.  
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Results 
Structural changes in p22phox associated with C242T SNP  
Computer modeling was used to investigate potential protein structural changes linked to p22phox 
C242T SNP9. Our consensus p22phox model showed that His72 (WT p22phox) is located within the 
extra-cellular region of the p22phox (Figure 1A), which has been identified to be essential for 
interaction with Nox212,26. The histidine residue contains a polar hydrophilic imidazole in 
comparison to the aromatic and hydrophobic tyrosine residue. The substitution of His72 to Tyr72 
alters the conformation of the extracellular region as shown by the backbone side-view (Figure 
1A, left panels) and top-view (Figure 1A, right panels). Root mean squared deviation (RMSD) 
calculations of extracellular structures of WT and C242T p22phox following energy minimization 
revealed significant difference between two structures (Figure 1C).  
 We next performed protein/protein docking of p22phox with a known Nox2 peptide (222-
HGAERIVR-229) that corresponds to the Nox2 extracellular region involved in binding to 
p22phox in a previous report27. We found that the Nox2 peptide interacted successfully with the 
WT p22phox extracellular domain and formed a hydrogen-bond between Arg226 of the Nox2 and 
Asn86 of the p22phox (Figure 1B, upper panels). However, this interaction was lost in the C242T 
model (Figure 1B, lower panels). Further docking experiments were performed using two Nox2 
peptides (peptide 1: 154-NFARKRIKNPEGGLY-168; peptide 2: 222-HGAERIVRG-230), 
which are located in the Nox2 extracellular domain and have been reported previously to be 
recognized by a Nox2 antibody (7D5)27 (Figure 2). We found several important hydrogen bonds 
(labeled by H) formed between the Nox2 peptides and the WT p22phox configuration, which 
further illustrated the importance of Nox2 Arg226 in stabilizing the interaction with WT p22phox. 
However, these links were disrupted by the C242T p22phox configuration. We also performed 
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HapMap analysis of the CEU (European) population, and found that the C242T SNP is only in 
strong correlation (r2 = 0.99) with one SNP located within a non-coding region of intron 4 
(rs12933505; Figure 1D). Moreover, the genotyped allele frequency of the CC (WT) and the CT 
and TT variants is 53% and 47%, respectively. This confirms the functional effect of C242T 
SNP is independent of other known p22phox SNPs at the protein level. 
Effect of C242T SNP on endothelial Nox2 activity 
The functional effect of p22phox C242T SNP on human endothelial Nox2 activity was firstly 
investigated by site-directed mutagenesis followed by gene transfection of human pulmonary 
microvascular endothelial cells (HPMECs) with or without acute TNFĮ (100 unit/ml; 30 min) 
stimulation. HPMECs displayed low levels of O2.- production at basal conditions (without TNFĮ 
stimulation) whereas TNFĮ increased significantly the levels of O2.- production in cells either 
transfected with an empty vector or with WT p22phox, without significant differences between 
them (Figure 3A). However, compared to WT p22phox, C242T p22phox had no significant effect 
on endothelial basal O2.- production, but did significantly inhibit TNFĮ-induced O2.- production 
(Figure 3A; right panel). The enzymatic sources of TNFĮ-induced O2.- production in vector or 
WT p22phox transfected cells was confirmed using human Nox2ds-tat peptide (a specific inhibitor 
of Nox2)28 and different enzyme inhibitors (Figure 3B). TNFĮ-induced O2.- production was 
inhibited significantly by Nox2ds-tat but not by NoxA1ds peptide (a specific inhibitor of Nox1, 
see Supplemental Figure 1) and was completely abolished by an O2.- scavenger (Tiron; 
10mmol/L) which confirmed the detection of O2.-. It was significantly inhibited by apocynin 
(100μmol/L, a Nox2 inhibitor) and diphenyliodium (DPI 20μmol/L, a flavoprotein inhibitor), but 
not by L-Nitroarginine-methyl-ester (L-NAME 100μmol/L, an eNOS inhibitor), oxypurinol 
(100μmol/L, a xanthine oxidase inhibitor) or rotenone (50μmol/L, a mitochondrial electron 
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transport chain inhibitor) (Figure 3B). Compared to WT p22phox transfected cells, C242T p22phox 
had no significant effect on Nox4 activity (H2O2 production) as shown using HEK293 cells (no 
endogenous Nox4 expression) co-transfected with Nox4 plus p22phox (Supplemental Figure 2). 
These data further confirmed a crucial role of Nox2-containing NADPH oxidase in TNFĮ-
induced endothelial O2.- production.  
 The inhibitory effect of p22phox C242T on TNFĮ-induced endothelial O2.-  production was 
further confirmed by two independent methods: DHE high-performance liquid chromatography 
(HPLC) detection of 2-OH-E+ (Figure 3C) and the tiron-inhibitable DCF-fluorescence 
microscopy using intact adherent endothelial cells (Figure 3D).  
Effects of C242T p22phox on endothelial Nox subunit expression and binding to p22phox  
The effects of p22phox C242T SNP on the basal levels of NADPH oxidase subunit expression was 
examined by Western blot. Compared to vector-transfected cells, the levels of p22phox expression 
were significantly increased in cells transfected with WT or C242T p22phox, which confirmed the 
success of gene transfection (Figure 4A). Nox1 expression was nearly undetectable. We found 
that C242T p22phox reduced significantly Nox2 expression without significant effect on Nox4 or 
Nox2 regulatory subunits i.e. p47phox, p67phox, p40phox and Rac1/2 and Nox4 as compared to cells 
transfected with vector or WT p22phox (Figure 4A).  
 Nox2 antibody 7D5 recognizes specifically an extracellular domain of human Nox2 and 
the levels of antibody 7D5 binding have been successfully used previously to indicate the levels 
of Nox2 maturation (cell surface membrane expression and stable cytochrome b formation) in 
cells27,29,30. Using flow cytometry, we found that TNFĮ increased significantly antibody 7D5 
binding to endothelial cells, and C242T p22phox reduced significantly the antibody 7D5 binding 
at both basal and in response to TNFĮ stimulation as compared to cells transfected with vector or 
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WT p22phox (Figure 4B). We then examined the effects of C242T p22phox on p22phox binding to 
Nox1, Nox2 and Nox4 by immuno-pull-down assay using p22phox antibody coated beads (Figure 
4C). Supplemental Figure 3 showed the molecular weights on full gel presentation, and the 
protein levels detected in the whole cell homogenates were shown in Supplemental Figure 4. The 
levels of Nox1 pulled-down by p22phox were barely detectable, and we could not see a significant 
effect of C242T p22phox on Nox1. Under basal condition (vehicle stimulated), there was no 
significant difference in the levels of Nox2 or Nox4 pulled-down by p22phox beads between cells 
transfected with vector or WT or C242T p22phox (Figure 4C). TNFĮ stimulation (24 h) increased 
significantly the levels of Nox2 and reduced the levels of Nox4 pulled-down by p22phox beads in 
vector or WT p22phox transfected cells. However, in cells transfected with C242T p22phox, TNFĮ-
induced Nox2 binding to p22phox was significantly reduced, while the levels of Nox4 binding to 
p22phox remained at vehicle levels as compared to vector or WT p22phox transfected cells. Taken 
together our results strongly suggested that p22phox C242T morphology inhibits specifically the 
interaction stability between Nox2 and p22phox and reduced TNFĮ-induced Nox2 activation in 
endothelial cells.  
Effects of C242T p22phox on TNFĮ-induced p22phox/p47phox binding and redox signaling 
through MAPKs and NF-țB in endothelial cells 
p22phox, through its intracellular C-terminal domain, anchors p47phox to Nox2 in the membrane to 
activate NADPH oxidase. In our computer model, C242T SNP was predicted not to affect 
p47phox membrane translocation and binding to p22phox. To confirm this, we prepared endothelial 
cell membrane fraction and examined for the membrane expression of p47phox by immunoblot 
(Figure 5A). Compared to vehicle control cells, TNFĮ stimulation significantly increased the 
levels of p47phox membrane expression without significant difference between vector and WT or 
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C242T p22phox transfected cells. We then immuno-precipitated p47phox and examined the levels 
of p22phox pulled down by p47phox beads and the levels of p47phox phosphorylation (Figure 5B). 
Compared to vehicle control cells, TNFĮ stimulation increased the levels of p22phox/p47phox 
complex formation and p47phox phosphorylation without significant difference between cells 
transfected with vector and WT or C242T p22phox. Membrane ROS production was shown in the 
Supplemental Figure 5. Once again, our data confirmed that the C242T p22phox inhibition of 
TNFĮ-induced endothelial O2.- production is specific to the Nox2 catalytic subunit.
Next, we examined the effect of C242T p22phox on TNFĮ-induced redox activation of 
extracellular regulated kinase-1/2 (ERK1/2), p38MAPK and NFțB in endothelial cells (Figure 5C). 
Compared to vehicle treated cells, TNFĮ stimulation increased significantly the levels of 
ERK1/2, p38MAPK and NFțBSer311 phosphorylation in WT p22phox transfected cells (Figure 5C), 
and these were accompanied by significant increases in endothelial apoptosis detected by 
annexin-V flow cytometry (Figure 5D). Interestingly, these TNFĮ effects were significantly 
inhibited in cells transfected with C242T p22phox. The levels of JNK phosphorylation was very 
low with no significant changes being detected after TNFĮ stimulation (data not shown). 
p22phox C242T inhibition of TNFĮ-induced endothelial vascular cell adhesion molecule-1 
(VCAM-1) expression and inflammation  
TNFĮ plays a key role in the pathogenesis of atherosclerosis and many other cardiovascular 
disorders. In order to explore the clinical significance of C242T p22phox in inhibiting 
inflammatory endothelial dysfunction, we examined TNFĮ (24 h)-induced endothelial expression 
of VCAM-1 and NFkB nuclear translocation by immunofluorescence (Figure 6A). Compared to 
vehicle treated cells, TNFĮ increased significantly the levels of NFțB (green) in the nuclei and 
VCAM-1 expression (red) mainly around the plasma membrane in cells transfected with vector 
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or WT p22phox, but not with C242T p22phox (Figure 6A). The inhibitory effect of p22phox C242T 
on TNFĮ-induced endothelial VCAM-1 expression was further confirmed by flow cytometry 
(Figure 6B). 
We examined also TNFĮ-induced monocyte adhesion to endothelial cells using FITC-
labelled U937 cells, and found that 24 h of TNFĮ stimulation increased significantly the number 
of monocytes attached to the endothelial monolayer in vector or WT p22phox transfected HPMEC 
but not in C242T p22phox transfected cells (Figure 6C). The inhibitory effect of C242T p22phox on 
endothelial Nox2 activation was further confirmed using cells stimulated with high level of 
glucose (25 mmol/L) (Supplemental Figure 6). 
Experiments using engineered p22phox-depl HeLa cells  
In order to confirm that our results of C242T p22phox would not be affected by the intrinsic 
p22phox protein expressed in HPMECs, we used engineered HeLa cells after p22phox depletion 
using a specific short-hairpin RNA (shRNA). A scrambled shRNA was used as controls in all 
experiments. The absence of p22phox protein in p22phox-depl cells was confirmed by 
immunoblotting (Figure 7A) and immunofluorescence (Figure 7B and Supplemental Figure 7). 
The p22phox protein was detected in scrambled shRNA treated cells and in p22phox-depl cells after 
gene transfection of WT or C242T p22phox (Figure 7A and B). Compared to scrambled shRNA 
treated control cells, the levels of both Nox2 and Nox4 were low in p22phox-depl cells, and 
increased to control levels after p22phox gene transfection. However, compared to WT p22phox 
transfected cells, the levels of Nox2 (but not Nox4) remained significantly lower in C242T 
p22phox transfected cells (Figure 7A). The levels of Nox1 expression was unaffected by the 
absence of p22phox. We then examined Nox2 maturation recognized by Nox2 antibody 7D5 and 
analyzed by flow cytometry (Figure 7C). Compared to scrambled shRNA control cells, p22phox-
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depl cells had significantly lower (19.5±2.8%) levels of Nox2 maturation, and this was restored to 
the control levels after WT p22phox transfection. However, the levels of Nox2 maturation 
remained significantly lower (58.7±2.3%) in C242T p22phox transfected cells. 
The levels of O2.- production by these cells were examined by lucigenin 
chemiluminescence in cell homogenates (Figure 7D, left panel) and the tiron-inhibitable DHE 
fluorescence flow cytometry (Figure 7D, right panel). Compared to scrambled shRNA treated 
control cells, p22phox-depl cells had significantly lower levels of O2.- production under basal 
condition and lost completely the O2.- response to TNFĮ stimulation. TNFĮ-induced O2.- 
production was restored to the scrambled shRNA control levels after gene transfection of WT 
p22phox. However, gene transfection of C242T p22phox only restored the basal but not the TNFĮ-
induced O2.- production  (Figure 7D). Reduced interaction between C242T p22phox and Nox2 (but 
not Nox4) after TNFĮ stimulation was further confirmed in p22phox-depl cells (Supplemental 
Figure 8).  
Experiments using Nox2-/- coronary microvascular endothelial cells (CMEC) 
In order to further confirm if C242T p22phox affected only Nox2 (but not Nox4 and/or Nox1), we 
isolated primary CMEC from wild-type and Nox2 knockout mice. Cells were then subjected to 
gene transfection and examined for O2.- production with or without TNFĮ stimulation 
(Supplemental Figure 9). Under basal conditions, Nox2-/- cells produced less O2.- compared to 
WT cells without significant differences between cells transfected with vector or WT p22phox or 
C242T p22phox. TNFĮ stimulation greatly increased the levels of O2.- production in WT CMEC 
transfected with vector or WT p22phox. Compared to WT p22phox transfected cells, p22phox C242T 
inhibited significantly the levels of TNFĮ-induced O2.- production (40±14% reduction) 
(Supplemental Figure 9). In contrast, TNFĮ increased only slightly (but still statistically 
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significant) the levels of O2.- production by Nox2-/- CMEC and there was no significant 
difference between cells transfected with vector, WT or C242T p22phox.  It was clear that C242T 
p22phox had no significant effect on TNFĮ-induced endothelial O2.- production in the absence of 
Nox2.  
C242T SNP frequency and inhibition of Nox2 expression and high-glucose induced ROS 
production in human saphenous veins  
In order to investigate the clinical significance, we genotyped 36 saphenous vein samples 
collected from patients after phlebectomies who had no history of coronary heart disease. We 
found that 50% samples were wild-type (CC), ~27.8% were heterozygotes (CT) and ~22.2% had 
p22phox C242T SNP (TT) with ~36.1% frequency of T allele appearance (Figure 8A). Dot-blot 
showed a significant reduction of Nox2 expression in TT vessels in comparison to CC vessels 
(Figure 8B). Immunofluorescence images revealed that the reduction of Nox2 was mainly in the 
endothelium (Figure 8D). It is well known that superoxide (O2·-) reacts with nitric oxide (NO) to 
form peroxynitrite which modifies tyrosine residue to form 3-nitrotyrosine (3NT), a biomarker of 
tissue oxidative damage. We found significantly lower levels of 3-nitrotyrosine (3NT) detected 
in TT samples as compared to CC samples (Figure 8C). When the vessels were challenged ex
vivo with high level of glucose (25 mmol/L) for 24 h, TT samples had significantly less ROS 
production in comparison to CC sample (Figure 8E). Superoxidase dismutase was used to 
confirm the detection of O2.-. 
Discussion 
The NADPH oxidase, by generating O2.-, plays a crucial role in the inflammatory response 
involved in the pathogenesis of many cardiovascular diseases. The p22phox is an integral 
 by guest on June 2, 2016http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.116.021993 
14 
membrane-associated subunit of NADPH oxidase responsible for assembling and stabilising Nox 
subunits into an active enzyme complex for ROS production8. A number of clinical studies have 
reported that individuals bearing a naturally-occurring p22phox C242T SNP have diminished O2.- 
production and are less susceptible to inflammatory cardiovascular diseases11,23,31,32. However, 
little progress has been made to clarify the underlying molecular mechanisms. For the first time, 
our study provides scientific evidence that p22phox C242T SNP causes p22phox structural changes 
in the extracellular domain that are unfavorable for Nox2 maturation and activation, and inhibits 
endothelial O2.- production in response to TNFĮ or high glucose stimulation. 
 A number of findings have been made by the current study in understanding the 
mechanism of p22phox C242T SNP inhibition of Nox2 activation: 1) There is a significant 
structural difference between WT and the C242T p22phox protein extracellular region that is 
important for Nox2 maturation12,33; 2) C242T p22phox structure compromises its binding stability 
with Nox2. The complex formed between Nox2 and C242T p22phox is less stable due to the 
lacking of crucial hydrogen bonds to bind them together. Unstable binding may led to Nox2 
protein degradation and this may explain the low levels of Nox2 detected in C242T p22phox 
transfected cells and in vein samples of TT individuals.  
The C242T SNP does not affect Nox1 because the Arg226 (crucial for the hydrogen bond 
formation to stabilize the interaction between Nox2 and WT p22phox) is replaced by Gly in Nox1. 
Furthermore, the putative epitope 1 (160-IKNP-163) that is required to interact with p22phox27 is 
absent in Nox1 (Supplemental Table 1). Nevertheless, Nox1 expression is extremely low in 
endothelial cells and is not a major source of endothelial ROS production in inflammation. Nox4 
is highly expressed in endothelial cells. Nox4 generates H2O2 and has been found to be involved 
mainly in cellular growth and normal function, and is protective to cardiovascular function34,35. 
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Using immunoblotting, real-time PCR (Supplemental Figure 10) and co-immunoprecipitation we 
have shown that C242T p22phox does not inhibit Nox4 expression or its complex formation with 
p22phox. Furthermore, using HEK293 cells that do not express endogenous Nox4, we have 
demonstrated that (after Nox4 gene transfection) C242T p22phox has no effect on Nox4 activity 
(Supplemental Figure 2). Under the basal condition (without TNFĮ), C242T p22phox has no effect 
on endothelial Nox2 mRNA expression (Supplemental Figure 10) but reduces the protein levels 
of Nox2 expression and Nox2 maturation. These results strongly suggest that the effect of C242T 
p22phox on Nox2 expression is post-translational. When the cells were challenged by TNFĮ, the 
inhibitory effect of C242T p22phox on TNFĮ-induced Nox2 mRNA expression (Supplemental 
Figure 10) is more likely due to reduced levels of oxidative stress and redox signaling (such as 
NFțB) that impair Nox2 transcription in C242T p22phox transfected cells.   
 Nox2 has low basal activity in endothelial cells and generates a small quantity of O2.- 
mainly used for redox-signaling under physiological conditions. Another important finding by 
the current study is that C242T p22phox configuration can still allow Nox2 to bind and support a 
low basal level of O2.- production. However, when the cells face challenge by TNFĮ C242T 
p22phox could not support a full Nox2 activation and thereby inhibits endothelial oxidative 
response to TNFĮ and protects endothelial cells from inflammation and cell apoptosis. The 
inhibitory effect of C242T p22phox on TNFĮ-induced endothelial ROS production by Nox2 was 
examined using four independent complementary methods: lucigenin-chemiluminecscence; 
DHE-HPLC; DHE-flow cytometry and DCF fluorescence microscopy and further confirmed by 
experiments using Nox2ds-tat, several enzyme inhibitors and Nox2-/- CMEC.  
Previously, C242T SNP was reported to form a haplotype correlated with two other 
p22phox SNPs: namely the C521T (rs1049254) and A24G (rs1049255) that reduced Nox2-activity 
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in Epstein-Barr virus-transformed B-lymphocytes isolated from 50 healthy individuals of an 
Utah pedigree33. However, our HapMap analysis could not identify a close correlation of C242T 
with any other SNPs of p22phox currently identified within the HapMap database. Our results 
strongly suggest that the functional effects of C242T SNP on NADPH oxidase are independent 
of any other known protein-translated p22phox SNPs. 
Using engineered p22phox-depl HeLa cells we further demonstrated that in the absence of 
p22phox, both Nox2 and Nox4 expressions were reduced, and could be restored after gene 
transfection of WT p22phox. However, gene transfection of C242T p22phox into p22phox-depl cells 
only fully restored the expression of Nox4 (but not Nox2). When cells were subjected to TNFĮ 
challenge, C242T p22phox transfected cells failed to increase O2.- production. C242T p22phox had 
no significant effect on its interaction with p47phox or on TNFĮ-induced p47phox phosphorylation. 
However, due to the inhibitory effect of C242T p22phox on Nox2 activation, TNFĮ-induced ROS 
production and redox-signaling through MAPK and NFțB were compromised in endothelial 
cells, which protected endothelial cells from oxidative damage and inflammation. 
Increased VCAM-1 expression and monocyte adherence to endothelial cells are crucial 
steps in the pathogenesis of inflammatory cardiovascular diseases. The clinical significance of 
C242T p22phox was demonstrated by showing that TNFĮ-induced endothelial VCAM-1 
expression and monocyte adherence to endothelial cells were significantly inhibited in C242T 
p22phox transfected cells. Saphenous veins are commonly used as conduits for bypass surgery to 
treat coronary artery diseases. Information on the p22phox genetic variation can predict graft 
oxidative response to environment challenge and help clinical management of vein grafts. We 
found a genetic frequency of 22.2% for TT genotype (36.1% for T allele) in our samples, which 
is in accordance to those reported previously for control samples or for the general population36-
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38. Using both dot-blotting and immunofluorescence, we confirmed that p22phox C242T SNP is 
indeed associated with reduced Nox2 expression mainly in the endothelium, and TT vessels had 
significantly less ROS generation in response to high glucose challenge as compared to CC 
vessels.   
Limitations need to be considered in the interpretation of our p22phox molecular models. 
Although our computer models are supported by extensive cell and molecular experimental data, 
the structural models still need to be confirmed by X-ray crystallography or nuclear magnetic 
resonance spectroscopy. 
In summary, this is the first report to describe the mechanism of p22phox C242T SNP in 
inhibiting Nox2 activity and protecting endothelial cells from TNFĮ-induced oxidative damage 
and inflammation. p22phox C242T SNP represents a natural protective mechanism against 
inflammatory cardiovascular diseases. The molecular mechanism reported here can be further 
explored for novel drug development.  
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Clinical Perspective 
NADPH oxidase, by generating reactive oxygen species, is involved in the pathophysiology of 
many cardiovascular diseases and represents a therapeutic target for the development of novel 
drugs. A number of clinic studies have reported that individuals bearing a naturally-occurring 
p22phox C242T single-nucleotide polymorphism (SNP) have diminished ROS production in the 
cardiovascular system and are less susceptible to inflammatory cardiovascular diseases. 
However, little progress has been made to clarify the underlying molecular mechanisms. The 
current study using computer molecular modelling plus cell and molecular techniques provides 
scientific evidence that p22phox C242T SNP causes p22phox structural changes in the extracellular 
domain that compromises its binding stability with Nox2 (the catalytic subunit of the NADPH 
oxidase) and reduces the levels of Nox2 protein expression and maturation. In response to TNFĮ 
challenge, C242T p22phox inhibits endothelial NADPH oxidase O2.- production, inflammatory 
VCAM-1 expression and monocyte adherence to endothelial cells. Clinical significance was 
investigated using saphenous vein segments from non-coronary heart disease subjects after 
phlebectomies. TT (C242T) allele was common (prevalence of ~22%) and compared to CC, 
veins bearing TT allele had significantly lower levels of Nox2 expression and O2.-  generation in 
response to high glucose challenge. C242T SNP may represent a natural protective mechanism 
against inflammatory cardiovascular diseases. The molecular mechanism reported in this study 
can be further explored for novel drug development. 
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Figure Legends: 
Figure 1. Computer modelling of p22phox structural changes associated with C242T SNP. (A) 
Morphological differences between WT and C242T p22phox structures (ribbon presentation).  (B) 
Docking of a Nox2-peptide (222-HGAERIVR-229) (skeleton in left panels and silver-space-fill 
in right panels) with p22phox extracellular domain (ribbon). Nox2 peptide interacts and forms an 
H-bond with the N86 (ball and stick presentation) of WT p22phox but not with the N86 of C242T 
p22phox. (C) RMSD calculations of the extracellular domain structural differences between WT 
and C242T p22phox following energy minimization. n=3 independent investigators. *p<0.05 for 
C242T values versus WT values (Mann-Whitney U-test). (D) Linkage disequilibrium (LD) plot 
from Haplo-view of common genotyped SNPs within the CYBA (p22phox) gene. The darker a 
diamond appears, the greater the correlation (r2 x 100) between the respective genotyped CYBA 
polymorphisms. The C242T SNP (rs4673) is outlined. 
 
Figure 2. Docking of two Nox2 peptides with p22phox extracellular domain. Images are shown as 
a tiled 45 degrees side-view/top-view. Two Nox2 peptides (peptide 1: 154-
NFARKRIKNPEGGLY-168; peptide 2: 222-HGAERIVRG-230) used for the docking have been 
reported previously to be the extracellular epitopes of Nox2 recognised by an antibody (7D5) to 
Nox2. WT p22phox configuration forms several hydrogen bonds (short grey dashed lines labelled 
by H) with Nox2 peptides. The location of Nox2 Arg226 is indicated. However, these interactions 
were lost in the C242T p22phox configuration. Red ribbons represent alpha helix. 
 
Figure 3. The effect of p22phox C242T SNP on HPMEC ROS production.  (A) Kinetic 
measurement of O2.- production. Area under curve (AUC) was calculated for each sample. 
 by guest on June 2, 2016http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.116.021993 
23 
*p<0.05 for TNFĮ AUC values verses vehicle AUC values analyzed by unpaired t-test with 
Welch’s correction. (B) Inhibition of O2.- production measured by lucigenin-chemiluminescence. 
Left panel: Nox2ds-tat peptide; Right panel: Effects of different enzyme inhibitors presented as 
percentages to TNFĮ values without inhibitor (filled bar). *p<0.05 for indicated values versus 
vehicle values under the same gene transfection. †p<0.05 for indicated values verses TNFĮ 
values (filled bar) under the same gene transfection. (C) O2.- production (2-OH-E) measured by 
DHE-HPLC. The amount of 2-OH-E was quantified against a standard curve and expressed as 
nmol/mg protein. (D) Intracellular ROS production examined by DCF fluorescence microscopy. 
Tiron was used to confirm the detection of O2.-. (C-D) *p<0.05 for TNFĮ values verses vehicle 
values under the same gene transfection. †p<0.05 for indicated values versus WTp22 TNFĮ 
values. Sample size (A-C): n=4 independent experiments; (D): n=3 independent experiments. 
 
Figure 4. NADPH oxidase subunit expression, Nox2 maturation and binding to p22phox in 
HPMEC. (A) Western blots. Optical densities (OD) of protein bands of p22phox, Nox1, Nox2, 
Nox4, p47phox, p67phox, p40phox and Rac1/2 were quantified and normalized to the levels of Į-
tubulin (loading control) detected in the same samples. (B) Flow cytometry for the binding of 
Nox2 antibody (7D5). *p<0.05 for indicated values versus to vector values. †p<0.05 for 
indicated values versus WT values. (C) Left panel: p22phox was immunoprecipited (IP) followed 
by immunoblotting (IB) of Nox1, Nox2 and Nox4. Right panels: Optical densities (OD) of 
protein bands were quantified and normalized to the levels of total p22phox detected in the same 
samples. *p<0.05 for indicated values versus vehicle values under the same gene transfection. 
†P<0.05 for indicated values versus WT TNFĮ values. n=4 independent experiments. 
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Figure 5. TNFĮ-induced p47phox membrane translocation and binding to p22phox, redox signaling 
and cell apoptosis in HMEC. (A) Western blot. The optical densities (OD) of protein bands were 
quantified and normalized to the levels of CD31 (an endothelial membrane marker) detected in 
the same samples. (B) p47phox was immunoprecipitated (IP) and detected by Western blot for the 
presence of p22phox and p47phox phosphorylation (P-p47). The optical densities (OD) of protein 
bands were quantified and normalized to the levels of total p47phox (T-p47) detected in the same 
samples. (C) Western blots. The phospho-bands were quantified and normalized to the total 
levels of the same protein detected in the same samples. (D) Right panels: Annexin-V/propidium 
iodide detection of cell apoptosis (upper right square) by flow cytometry. Apoptotic cells were 
presented as a percentage of total cells (20,000). *p<0.05 for indicated value versus vehicle 
values under the same gene transfection. †p<0.05 for indicated values versus WTp22 TNFĮ 
values. n=4 independent experiments. 
 
Figure 6. TNFĮ-induced NFțB nuclear translocation, VCAM1 expression and monocyte 
adherence in HPMECs. (A) Immunofluorescence microscopy detection of NFkB (green) nuclear 
translocation and VCAM1 (red) expression.  Nuclei were labelled with DAPI (blue) to visualize 
cells. The fluorescence intensity was quantified from 20 images/per group. n=3 independent 
experiments. (B) Flow cytometry detection of VCAM-1 expression. (C) U937 monocytes were 
labeled with FITC (green) and the number of monocytes adhering to the HPMEC monolayer was 
counted for quantification. *p<0.05 for indicated value versus vehicle values under the same 
gene transfection. †p<0.05 for indicated values versus WTp22 TNFĮ values. n=4 independent 
experiments (B-C) . 
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Figure 7. Experiments using p22phoxdepl HeLa cells. (A) Western blots. Optical densities (OD) of 
protein bands were quantified and normalized to the levels of Į-tubulin detected in the same 
sample. (B) Immunofluorescence detection of p22phox expression. The color images and 
quantification of p22phox fluorescence intensities are presented in the Supplemental Figure 7. (C) 
Flow cytometry detection of anti-Nox2 antibody (7D5) binding to HeLa cells. Shaded area 
represents control cells without Nox2 antibody labelling. (D) O2.- production. SCR: scrambled 
shRNA. *p<0.05 for indicated values versus SCR values under the same treatment. †p<0.05 for 
indicated values versus WTp22 values under the same treatment. n=4 independent experiment.  
 
Figure 8. The effects of C242T p22phox SNP on Nox2 expression and high-glucose induced ROS 
production in human saphenous veins. (A) Genotyping of C242T p22phox SNP (left panel) and 
calculated frequency in a total of 36 samples. WT p22phox appeared as a single band of 348 bp 
and C242T SNP had two bands at 188 and 160 bp.   B) Nox2 expression detected by dot-
blotting. C) 3NT formation detected by dot-blotting. *p<0.05 for indicated values versus CC 
values. D) Nox2 (red color) expression detected by Immunofluorescence. Lumen was labeled for 
the location of the endothelium. Vessel structure was shown by H&E staining (right panel).  E) 
Left panels: Representative images of vessel ROS production with or without high-glucose (H-
glucose) challenge (24 h) detected by DHE fluorescence on vessel sections. Superoxide 
dismutase (SOD) was used to confirm the detection of O2.-. *p<0.05 for indicated values versus 
control values in the same genetic group. †p<0.05 for indicated values versus CT values under 
H-glucose. 
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D) Endothelial cell apoptosis
Figure 5
C) MAPK and NFkB activation
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 SUPPLEMENTAL MATERIAL 
Materials and methods 
Reagents 
Human recombinant TNFα was from Roche Applied Sciences. Polyethyleneimine (linear 
MW=25,000) was from Polysciences Inc (UK). Rabbit and goat polyclonal antibodies to 
NADPH oxidase subunits Nox1, Nox2, Nox4, p22phox, p47phox, p67phox, rac1, total ERK1/2, 
p38 MAPK, total JNK, NFκB, phosphor-NFκBSer311, CD31 and α-tubulin were purchased 
from Santa Cruz (UK). Monoclonal antibody to p40phox was from Upstate Biotechnology. 
Antibodies to phospho-ERK1/2, phospho-p38 MAPK, phospho-JNK were from Cell 
Signalling Technology. Dihydroethidium (DHE) and 5-(and 6)-chloromethyl-2’,7’-
dichlorodihydrofluorescein diacetate (DCF) were from Invitrogen. Other reagents were from 
Sigma except where specified.  
In silico protein structural modelling and protein docking 
 The in silico model of p22phox was generated as reported previously by incorporating 
data from the online prediction servers with the molecular operating environment (MOE; 
Chemical Computing Group Inc., Canada) and subjected to energy minimization using the 
AMBER99 force field until all unfavorable residue contacts and atom clashes were repaired 
as described previously1,2. To calculate differences in the WT and C242T extracellular 
domains, the root-mean squared deviation (RMSD) was investigated by superimposing alpha-
carbon backbone atoms in MOE, expressed in angstroms (Å) as described previously1, 2. 
RMSD results were collected from three independent modeling experiments and expressed as 
Mean±SD of 3 sets of data. The docking of p22phox with Nox2 peptide was performed in the 
MOE program and refined by energy minimization using the AMBER99 forcefield as 
described previously2. 
HapMap analysis of the CYBA gene 
 Using the International HapMap Project (HapMap phase II+III; dbSNP b126), 6 
common CYBA SNPs were chosen from the National Centre for Biotechnology Information 
(NCBI) SNP database (dbSNP). Haplotype association was calculated using the Haplo-view 
analysis program (version 4.2) in the northern and western European population (CEU) and is 
expressed as r2. CYBA SNPs in complete linkage disequilibrium have an r2 correclation value 
of 100%. 
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Site-directed mutagenesis 
The recombinant human p22phox cDNA sequence (GenBank:BC006465.1) subcloned 
into pcDNA3.1 (Invitrogen) at Xba I and Hind III sites was a kind gift from Prof. J.D. 
Lambeth (Emory University, USA). Primer design and the site-directed mutagenesis 
experiments were performed according to the manufacturer’s instruction using the 
QuikChange Multi Site-Directed Mutagenesis kit (Agilent Technologies) as described 
previously3. The PCR products of these mutations were cloned into E.coli, DH5α (Invitrogen), 
and the C242T substitution of the p22phox was verified by molecular sequencing. 
Cell culture, Gene transfection and TNFα stimulation 
 Human pulmonary microvascular endothelial cells (HPMEC-ST1.6R) were a kind gift 
from Dr R. Unger (Johannes Gutenberg University, Germany)4 and were cultured in M199 
medium containing 10% (v/v) fetal bovine serum (FBS), 20µg/ml of endothelial cell growth 
supplement (ECGS) and 25µg/mL heparin. The monocytic cell line (U937) was obtained 
from ATCC and grown in RPMI medium supplemented with 10% (v/v) FBS, 2mmol/L L-
glutamine, 100U/mL penicillin and 100µg/mL streptomycin. CMEC were isolated from the 
hearts of 10-12 week old Nox2 KO and WT mice and cultured as described previously and 
used at passage 25,6. The shRNA p22phox targeted sequence is: 
GGCCCTTTACCAGGAATTA, and the shRNA scrambled control sequence is 
GACAACGTATCCGTCAGTT.  The shRNA p22phox (p22phox-depl) and shRNA scrambled 
control HeLa cells were generated using the techniques as described previously7 in the 
laboratory of Professor Krönke (University of Cologne, Germany). Gene transfection was 
performed exactly as described previously using polyethyleneimine3. Transfection efficiency 
(65-70%) was verified with a reporter gene, β-galactosidase3. After 48h of culture, cells were 
treated with either vehicle or TNFα (100 U/mL) for 30 min or 24 h according to the 
experimental design in 5% FCS/DMEM and harvested for further experiments.  
Preparation of cell membrane fraction 
 Cellular membrane protein fraction was prepared as described previously 8. Briefly, 
cells were detached by mechanical scraping and then were re-suspended in MOPS-KOH 
buffer (MOPS-KOH 20mmol/L, sucrose 250mmol/L, pH 7.4). Cell homogenate was quickly 
centrifuged at 1,475g for 15 min. to remove any unbroken cells and the nuclei-enriched 
fraction. The resulting supernatant was then centrifuged for 15 min. at 29,000g to pellet 
mitochondria and subcellular organelles. The resulting supernatant was centrifuged for 60 
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min. at 100,000g to produce a membrane fraction. Pellets of the membrane fraction were re-
suspended in homogenization buffer and washed once before using. 
Human saphenous vein sample collection, genotyping and glucose challenge.  
Segments of human saphenous vein were collected from 36 patients (without histories 
of coronary heart diseases) undergoing phlebectomies at a specialist vein unit. Informed 
consent was obtained from the patients and the project was approved by the local NHS and 
the University ethical committees. Vein segments (3-5 mm long) with normal morphological 
appearance were used for the experiments. The C to T substitution at 242 in the CYBA 
coding sequence was examined exactly as described previously using specific intron-
spanning primers (forward: 5’CGCTGGCGTCCGGCCTGATCCTCA3’; reverse: 
5’ACGCACAGCCGCCAGTAGGTAGAT3’)9. Expression of the T-allele produces two 
bands at 160- and 188-bp respectively, whereas the C-allele has one band at 348-bp. For the 
experiments of high-glucose challenge, vessel segments were then cultured in the 5% 
FCS/M199 medium with normal glucose (5 mmol/L) or high glucose (25 mmol/L) for 24 h 
before ROS measurement.  
Measurement of ROS production  
Endothelial (or vessel tissue) O2.- production was measured using four independent 
methods as described previously10. 1) Lucigenin (5µmol/L)-chemiluminescence (BMG 
Lumistar, Germany). The assay specificity for O2.- detection was confirmed by adding tiron 
(10mM), a non-enzymatic scavenger of O2.-. Potential enzymatic sources of O2- production 
were also investigated by using the following inhibitors: Nox2 –ds-tat (10 µmol/L), apocynin 
(100µmol/L), N-ω-nitro-L-arginine methyl ester (L-NAME, 100µmol/L), rotenone 
(50µmol/L), oxypurinol (100µmol/L) or diphenyleneiodonium (DPI, 20µmol/L). 2) DHE 
fluorescence HPLC assay with or without superoxide dismutase–polyethylene glycol (PEG-
SOD) was performed exactly as described previously3, 11. The amount of 2-OH-E generated 
was normalized to the protein concentration of the same sample. 3) The intracellular O2.- 
production was examined using DHE flow cytometry in the presence or absence of tiron. 4) 
The ROS production by adherent cells was measured using DCF fluorescence acquired under 
Olympus BX61 fluorescence microscopy. Fluorescence intensity was quantified from at least 
3 random fields (269.7 x 269.2 µm) per chamber, >100 cells were assessed per cell culture 
experiment, and at least 3 separate cell cultures per condition3. 
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Amplex Red assay for H2O2 measurement 
Total cell homogenate H2O2 production was measured using the Amplex Red 
(Invitrogen Inc.) assay as described previously12. Briefly, 50 µg/ml protein was added to the 
wells of a black 96-well plate containing the assay buffer (25 mmol/L HEPES, pH 7.4, 
containing 0.12 mol/L NaCl, 3 mmol/L KCl, 1 mmol/L MgCl2, 0.1 mmol/L Amplex red, and 
0.32 U/ml HRP). The reaction was initiated by the addition of 36 μmol/L NADPH and 
detected using a BMG Fluostar Galaxy multimode microplate reader. Catalase (300 U/ml) 
was added in the parallel wells. H2O2 production was quantified against a standard curve. 
Quantitative real-time (RT)-PCR 
These experiments were performed as described previously13 using human primers for 
Nox1 (F: CAGGGAGACAGGTGCCTTTTCC; R: GAACCAGAGCAGTCCAAACTCG), 
Nox2 (F: CAAGATGCGTGGAAACTACCTAAGAT; R: 
TCCCTGCTCCCACTAACATCA) and Nox4 (F: CTGCTGACGTTGCATGTTTC; R: 
TTCTGAGAGCTGGTTCGGTT), β-actin, (F: CTGGCACCCAGCACAATG; R: 
GCCGATCCACACGGAGTACT). Each gene expression levels were normalized to β-actin, 
and expressed log2 ratio of ΔCt values.  
Immunoprecipitation and immunoblotting 
 Immunoblotting experiments were performed exactly as described previously 6. The 
α-tubulin detected in the same sample was used as a loading control. Co-immunoprecipitation 
(IP) was performed as described previously using anti-p22phox or anti-p47phox antibody coated 
protein G agarose beads14. Normal rabbit IgG-coupled beads were used as negative controls. 
Samples were then examined for the presence of other Nox subunits pulled down by the 
beads using immunoblotting (IB). The levels of total p22phox or total p47phox in the same IP 
sample were used as loading controls. 
Dot blotting 
Human vessel Nox2 expression and protein nitration were detected by dot-blot 
analysis according to a previous publication15 using 5 µl (50 µg) of protein samples. 
Immuno-blotting was performed using specific antibodies to Nox2 or 3-nitrotyrosine (3NT). 
Positive labelling was detected by fluorescence (Cy5 or FITC)-conjugated secondary 
antibodies. Blots were scanned using a fluorescence imager (Typhoon Trio, Amersham) and 
quantified. 
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Flow cytometry 
This was done exactly as described previously16. Briefly, cells were trypsinized, 
washed in PBS supplemented with 1% BSA and 1% FCS. Cells were then incubated on ice 
for 30 min with primary antibodies (as indicated in the text) or buffer only as controls. After 
washing, cells were then incubated with FITC- or Cy3-labelled specific secondary antibodies. 
Fluorescence intensity of cells was measured using Accuri C6 flow cytometer (BD 
Bioscience). Data were analyzed with the Accuri C6 software.  
Immunofluorescence microscopy 
Cell preparation and immunofluorescence microscopy were performed as described 
previously8. Cells were labelled with primary antibodies and detected using biotin-conjugated 
anti-rabbit or anti-goat IgG (1:1000 dilution) as the secondary antibodies. Specific antibody 
binding was detected by extravidin-FITC (green) or streptavidin-Cy3 (red).  Normal rabbit or 
goat IgG (5µg/mL) was used in place of primary antibody as negative controls. Images were 
acquired with an Olympus BX61 fluorescence microscope system. Fluorescence intensities 
were quantified as described above. 
Statistics  
Data were presented as means ± SD of results taken from at least 3 independent cell 
cultures and gene transfections for each condition. In the case of CMEC, each isolation used 
6 mice/per group, and the data presented were the means ± SD from at least 3 separate 
CMEC isolations. Comparisons were made by ANOVA with Bonferroni test analysis except 
where it was specified in the figure legend. P<0.05 was considered statistically significant.  
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Supplemental Table I. 
Differences in the trans-membrane domain sequences (300 amino acids) between Nox2 and 
Nox1.  
Nox2: 
Nox1: 
 
1-MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACL 
1-MGNWVVNHWFSVLFLVVWLGLNVFLFVDAFLKYEKADKYYYTRKILGSTLACARASALCL 
Nox2: 
Nox1: 
 
61-NFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHL 
61-NFNSTLILLPVCRNLLSFLRGTCSFCSRTLRKQLDHNLTFHKLVAYMICLHTAIHIIAHL 
Nox2: 
Nox1: 
 
121-FNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGV 
121-FNFDCYSRSRQATDGSLASILSSLSHDEKKGGSWLNPIQSRNTTVEYVTFTSIAGLTGVI 
Nox2: 
Nox1: 
 
181-VITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHN 
181-MTIALILMVTSATEFIRRSYFEVFWYTHHLFIFYILGLGIHGIGGIVRGQTEESMNESHP 
Nox2: 
Nox1: 
241-ITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKV 
241-RKCAESFEMWDDRDSHCRRPKFEGHPPESWKWILAPVILYICERILRFYRSQQKVVITKV 
 
Two epitopes (yellow colour shaded areas, epitope 1: 160-INKP-163 and epitope 2: 226-
RIVRG-230) in the extracellular region of Nox2 are found to be involved in the interaction 
with p22phox (details in Figure 2), and are recognised by antibody 7D5. Sequence homology 
matching table shows that Nox1 does not contain the sequence of epitope 1. In the sequence 
of epitope 2, the key positively charged amino acid (Arg226) of Nox2 that forms the crucial 
hydrogen bond with Asn86 of p22phox (see Figure 2) is substituted by the smallest and 
uncharged amino acid (Gly225) in Nox1.   
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Supplemental Figure I: Inhibition of TNFα-induced O2.- production by human 
coronary arterial endothelial cells (HCAEC) using specific peptide inhibitors to 
Nox1 and Nox2.
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HCAEC were cultured in the complete culture medium. Peptides (10 µmol/L) were added into the
culture medium 1 h before TNFα stimulation. Cells were then stimulated by TNFα (100 U/ml) for
30 min. NADPH-dependent O2.- production by cell homogenates was measured by lucigenin (5
µmol/L)-chemiluminescence. *p<0.05 for indicated values versus vehicle values in the same
peptide treatment group. †p<0.05 for indicated values versus TNFα values in the scrambled
peptide (SCR-tat) treatement group. n=4 separate experiments.
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Supplemental Figure II: Nox4-derived H2O2 production by HEK293 cells co-
transfected with Nox4 plus WT or C242T p22phox
HEK293 cells were co-transfected with human Nox4 plus either WT or C242T p22phox plasmids.
Cells were then stimulated with or without TNFα for 30 min. The H2O2 production was measured
in cell homogenates by Amplex-red assay in the presence or absence of catalase (300 units/ml).
*P<0.05 for indicated values versus vector values under the same treatment. †p<0.05 for catalase
values versus vehicle or TNFα value in the same gene transfection group. n=4 separate gene
transfection experiments.
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p22phox was immunoprecipitated (IP) and detected by immunoblotting (IB) for 
the existence (pulled-down) of Nox2, Nox1 and Nox4 (in Figure 3C). The 
molecular weights are indicated on the left. 
IB: Nox1
IB: Nox4
Supplemental Figure III: Representative examples of Western blots of co-
immunoprecipitatiion (used in Figure 3C).
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Supplemental Figure IV. The effect of C242T p22phox on TNFα-induced Nox2 and 
Nox4 protein expression in HPMEC (Input data for Figure 4C).
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The whole cell homogenates were used for Western blots. Optical density of protein 
bands were quantified and normalized to α-tubulin detected in the same sample. 
*p<0.05 for TNFα values versus vehicle values in  the same gene transfection 
group. †p<0.05 for indicated values versus WT TNFα values. #p<0.05 for indicated 
values versus vector vehicle values. n=4 separate gene transfection experiments.
* *
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Supplemental Figure V. Effects of p22phox C242T SNP on TNFα -induced O2.-
production by endothelial membrane fractions
0
50
100
150
200
250
300
350
M
LU
/0
.
1m
g 
pr
o
te
in
*
Vector WTp22 C242T
**
HPMEC membrane fraction was prepared as described in the method. NADPH-
dependent O2.- production was  measured by lucigenin (5 µmol/L)-
chemiluminescence. *p<0.05 for indicated values versus vehicle values in the 
same gene transfection group. †p<0.05 for indicated values versus WT TNFα
values.
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Supplemental Figure VI. Effects of p22phox C242T SNP on high glucose (25 
mmol/L)-induced O2.- production 
HPMEC were cultured in the presence of normal glucose level (5 mmol/L) or high-
glucose level (25 mmol/L) for 24 h. NADPH-dependent O2.- generation by cell 
homogenates was measured by lucigenin (5 µmol/L)-chemiluminescence. 
*p<0.05 for indicated values versus 5 mM glucose values in the same gene 
transfection group. †p<0.05 for indicated values versus vector or WT p22phox
transfected 25 mmol/L glucose values. n=4 separate gene transfection 
experiments.
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For quantification, results are means ± SD from 30 images of 3 independent 
experiments. *p<0.05 for indicated value versus SCR values.
Supplemental Figure VII. Colour presentation and quantification of the p22phox 
fluorescence intensity in HeLa cells presented  in Figure 7B
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Supplemental Figure VIII. p22phox binding to  Nox isoforms in p22phox depleted 
HeLa cells. 
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A) Western blots  of whole cell homogenates (Input of B). Optical densities (OD) of 
protein bands were quantified and normalised to α-tubulin detected in the same 
sample. *P<0.05 for TNFα values versus vehicle values in  the same gene 
transfection group. #P<0.05 for indicated values versus vector vehicle values. 
†P<0.05 for indicated values versus WTp22 TNFα values. B) p22phox was 
immunoprecipited (IP) followed by immunoblot (IB). The results were normalized to 
the levels of total p22phox detected in the same samples. *p<0.05 for indicated 
values versus vehicle values under the same gene transfection. †p<0.05 for 
indicated values versus WTp22 TNFα values. n=4 separate gene transfection 
experiments. 
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WT and Nox2 knockout (KO) CMEC were transfected with an empty vector or WT 
p22phox or C242T p22phox plasmids. Cells were then stimulated with TNFα for 30 
min. The O2.- production was measured by lucigenin (5 µmol/L)-
chemiluminescence. n=3 separate cell isolations (6 mice/per isolation). *p<0.05 
for indicated values versus vehicle values in the same gene transfection group. 
†p<0.05 for indicated values versus WTp22 TNFα values.
Supplemental Figure IX. TNFα-induced O2.- production by coronary 
microvascular endothelial cells (CMEC) isolated from WT and Nox2KO mice
Supplemental Figure X. Real-time PCR detection of Nox mRNA expressions in 
HPMEC.
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A) Basal Nox1, Nox2 and Nox4 mRNA expression (without TNFα). B) Fold changes 
of Nox1, Nox2 and Nox4 mRNA expression in response to TNFα (24 h) stimulation. 
The values of vector transfected control cells for each gene were expressed as 1. 
*p<0.05 for TNFα values versus vehicle values in the same gene transfection group. 
†p<0.05 for indicated values versus WT TNFα values. n=4 independent gene 
transfection experiments.
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